MRC2 and fibrosarcoma: In a preclinical study the antitumor efficacy of 2h9-vc-MMAE, an ADC composed of an anti-uPARAP mAb linked to MMAE was evaluated in fibrosarcoma (FS) and RMS cell lines (HT1080 and RD, respectively), expressing high levels of uPARAP.